More

    Tag: toxicology

    Ryan K. Stansfield: Director, DMPK-Toxicology at 858 Therapeutics

    Ryan K. Stansfield is a seasoned leader with over 23 years of experience in small molecule drug discovery and development. Currently serving as Director of DMPK-Toxicology at 858 Therapeutics, he has successfully led teams through critical phases of drug development, including managing IND-enabling toxicology studies and building high-performing scientific teams. Stansfield is recognized for his deep expertise in ADME, safety pharmacology, and toxicology, as well as his strategic ability to drive projects from discovery to clinical trials. Throughout his career, he has demonstrated exceptional communication skills, collaborating across functions and ensuring timely, rigorous data to support regulatory submissions. With a proven track record in managing budgets, experimental design, and in-licensing diligence, Stansfield has contributed to the successful advancement of multiple therapeutic candidates.
    Executive Biography

    © LEADAFI, Elevating Leadership, one article at a time.

    Lead-afi (verb): The act of improving, enhancing, or amplifying the leadership qualities of an individual or group, with the goal of establishing their executive brand and authority in their industry. This could mean coming up with and sharing a clear and compelling vision, building a strong personal brand, and getting known for being a thought leader and expert. Through Leadafi, executives can increase their visibility and influence within their industry, and position themselves as trusted and respected leaders.